{"id":132619,"date":"2017-06-01T21:43:26","date_gmt":"2017-06-02T01:43:26","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/uncategorized\/biotech-no-downside-risk-here-barrons.php"},"modified":"2024-08-17T16:09:18","modified_gmt":"2024-08-17T20:09:18","slug":"biotech-no-downside-risk-here-barrons","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/biotechnology\/biotech-no-downside-risk-here-barrons.php","title":{"rendered":"Biotech: No Downside Risk Here – Barron’s"},"content":{"rendered":"
\"\"
Barron's<\/font><\/a><\/font><\/td>
\"\"<\/div>
Biotech: No Downside Risk Here<\/b><\/a>
Barron's<\/font><\/b><\/font>
Both the iShares Nasdaq Biotechnology<\/b> ETF (IBB) and the SPDR S&P Biotech ETF (XBI) have risen 1.5% and 2.4% respectively, so far on Thursday. Oppenheimer's Leah Rush Cann notes that biotech stocks are trading at a 30% premium to the market.<\/font>
Compton Capital Management Inc. RI Boosts Position in iShares NASDAQ Biotechnology<\/b> Index (IBB)<\/a>The Cerbat Gem<\/nobr><\/font><\/font>
Neville Rodie & Shaw Inc. Boosts Position in iShares NASDAQ Biotechnology<\/b> Index (IBB)<\/a>Sports Perspectives<\/nobr><\/font><\/font>
Alethea Capital Management LLC Maintains Stake in iShares NASDAQ Biotechnology<\/b> Index (IBB)<\/a>Chaffey Breeze<\/nobr><\/font><\/font>
BBNS<\/nobr><\/a><\/font>
all 23 news articles »<\/b><\/nobr><\/a><\/font><\/div>

<\/p><\/font><\/td><\/tr><\/table>

<\/p>

Read more here:
Biotech: No Downside Risk Here - Barron's<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Barron's Biotech: No Downside Risk Here Barron's Both the iShares Nasdaq Biotechnology ETF (IBB) and the SPDR S&P Biotech ETF (XBI) have risen 1.5% and 2.4% respectively, so far on Thursday. Oppenheimer's Leah Rush Cann notes that biotech stocks are trading at a 30% premium to the market. Compton Capital Management Inc. Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246860],"tags":[],"class_list":["post-132619","post","type-post","status-publish","format-standard","hentry","category-biotechnology"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/132619"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=132619"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/132619\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=132619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=132619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=132619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}